Status:
UNKNOWN
Investigation of the Strategy of Preventing Post-operative Opioid-induced Hyperalgesia
Lead Sponsor:
Tri-Service General Hospital
Conditions:
Opioid-Induced Disorders
Eligibility:
FEMALE
20-80 years
Phase:
PHASE4
Brief Summary
The concept of Enhanced Recovery After Surgery(ERAS) has been prevalent in recent years. In the ERAS guideline, short-acting anesthetics, instead of long-acting opioid anesthetics, were recommended du...
Detailed Description
1. After obtaining informed consent, patients will be randomized into two groups. 2. All patients receive remifentanil-propofol based TIVA and Bispectral index (BIS) monitor during breast surgery. In ...
Eligibility Criteria
Inclusion
- Subject's ASA (American Society of Anesthesiologists) Physical Status Classification: I (A normal healthy patient)\~III(A patient with severe systemic disease)
- Subject has breast cancer and scheduled for breast surgery using total-intravenous anesthesia(TIVA)
Exclusion
- Subject's ASA (American Society of Anesthesiologists) Physical Status Classification \>3
- Subject doesn't receive total-intravenous anesthesia(TIVA) during surgery
- Subject has psychiatric disease
- allergic to opioid or propofol
- History of alcoholism
- History of drug abuse
Key Trial Info
Start Date :
January 11 2019
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 31 2019
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT03812003
Start Date
January 11 2019
End Date
December 31 2019
Last Update
January 22 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Tri-Service General Hospital
Taipei, Taiwan, 114